Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: A comparative matched cohort study

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 917-922

  Fleming, D R ^a,b,h   Henslee Downey, P J ^a,c   Romond, E H ^a   Harder, E J ^a   Marciniak, E ^a   Munn, R K ^a   Messino, M J ^a,d   Macdonald, J S ^a,e   Bishop, Michael ^a,f   Rayens, M K ^g   Thompson, J S ^a   Foon, K A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Regional Oncology Associates   (United States)

^e TEMPLE UNIVERSITY   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^h UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lymphoblastic leukemia; Allogeneic bone marrow transplantation; Partially matched related donors; T cell depletion

Indexed keywords

CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOTOXIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RELATIVE; REMISSION; SIBLING; SURVIVAL; T LYMPHOCYTE;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 8944251129     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Butturini A, Gale R. Chemotherapy versus transplantation in acute leukemia. Br J Haematol 1989; 72: 1-8.
2. Barrett J, Horowitz M, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989; 74: 862-871.
3. Buchanan G. Diagnosis and management of relapse in acute lymphoblastic leukemia. In: Pochedly C, Levin C (eds). Hematology/Oncology Clinics of North America, Childhood Acute Lymphoblastic Leukemia, Part II. WB Saunders: Philadelphia, 1990, pp 971-995.
4. Horowitz M, Messer D. Hoelzer et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 1991; 115: 13-18.
5. Billett A, Kornmehl E, Tarbell N et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 1993; 81: 1651-1657.
6. Simonsson B, Burnett A, Prentice T. Autologous bone marrow transplantation with monoclonal antibody purged marrow for high-risk acute lymphoblastic leukemia. Leukemia 1989; 3: 631-636.
7. Blume K, Schmidt G, Chao N, Forman S. Bone marrow transplantation from histocompatible sibling donors for patients with acute lymphoblastic leukemia. Hematol Bluttransfus 1990; 33: 636-637.
8. Doney K, Fischer L, Appelbaum F et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariant analysis of factors affecting acute graft-versus-host disease and relapse and relapse-free survival. Bone Marrow Transplant 1991; 7: 453-459.
9. Terasaki PI, McLellan JD. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998-1000.
10. Henslee PJ, Byers VS, Jennings CD et al. A new approach to the presentation of graft-versus-host disease (GVHD) using Xomazyme H65 following histocompatible partially T-depleted marrow transplantation. Transplant Proc 1989; 21: 3004-3007.
11. Marciniak E, Romond EH, Thompson JS, Henslee PJ. Laboratory control in predicting clinical efficacy of T-cell depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysis. Bone Marrow Transplant 1988; 3: 589-598.
12. Henslee PJ, Thompson JS, Romond EH et al. T-cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect. Transplant Proc 1987; 19: 2701-2706.
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Asssoc 1958; 53: 457-481.
14. Cox D. Regression models and life tables (with discussion). JR Stat S[B] 1972; 34: 187-220.
15. Thomas E, Storb R, Clift R et al. Bone marrow transplantation. New Engl J Med 1975; 292: 895-902.
16. Sullivan K. Acute and chronic graft-versus-host disease in man. Int J Cell Clon 1986; 4: (Suppl. 1): 42-93.
17. Blume K, Schmidt G, Chao N. Bone marrow transplantation for acute lymphoblastic leukemia. In: Gale RP, Koelzer D (eds). Acute Lymphoblastic Leukemia. Alan R. Liss: New York, 1990, pp 279-283.
18. Rivera G, Buchanan G, Boyett J et al. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. New Engl J Med 1986; 315: 273-278.
19. Henze G, Fengler R, Hartmann R et al. Six-year experience with comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia. A relapse study of the BFM group. Blood 1991; 78: 1166-1172.
20. Altschuler C, Resbeut M, Blaise D et al. Fractionated total body irradiation and bone marrow transplantation in acute lymphoblastic leukemia. Int J Radiat Oncol Biol Phys 1990; 19: 1151-1154.
21. Beatty P, Clift R, Mickelson E et al. Marrow transplantation from related donors other than HLA-identical siblings. New Engl J Med 1985; 313: 765-771.
22. Powles R, Pedrazzini A, Crofts M et al. Mismatched family bone marrow transplantation. Semin Hematol 1984; 21: 182-187.
23. Pirsch J, Maki D. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Ann Intern Med 1989; 320: 197-204.
24. Skinner J, Finlay J, Sondel P, Trigg M. Infectious complications in pediatric patients undergoing transplantation with T-lymphocyte-depleted bone marrow. Pediatr Infect Dis J 1986; 5: 319-324.
25. Anasetti C, Amos D, Beatty P et al. Effect of HLA-compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New Engl J Med 1989; 320: 197-204.
26. Martin J, Hansen J, Thomas E. Preincubation of donor bone marow cells with a combination of murine anti-T cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation. J Clin Immunol 1984; 4: 18-22.
27. Butturini A, Gale RP. T-cell depletion in bone marrow transplantation for leukemia: current results and future directions. Bone Marrow Transplant 1988; 3: 185-192.
28. Maraninchi D, Blaise D, Rio B et al. Impact of T-cell depletion on outcome of allogeneic bone marrow transplantation for standard risk leukemias. Lancet 1987; 2: 175-178.
29. Champlin R, Gajewski J, Feig S et al. Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation. Transplant Proc 1989; 21: 2947-2948.
30. Champlin R, Lee K. T-cell depletion to prevent graft-versus-host disease following allogeneic bone marrow transplantation. In: Areman E, Deeg H, Sacher R (eds). Bone Marrow and Stem Cell Processing. FA Davis: Philadelphia, 1992, pp 163-170.
31. Drobyski W, Ash R, Casper J et al. Effects of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 1980-1987.
32. Weisdorf D, Filipovich A, McClare P et al. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA (Xomazyme-CD5)) plus methotrexate and cyclosporin or prednisone after unrelated donor marrow transplantation. Bone Marrow Transplant 1993; 12: 531-536.
33. Koehler M, Hurwitz CA, France RA et al. Xomazyme-CD5 immunotoxin in conjunction with partial T-cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors. Bone Marrow Transplant 1994; 13: 571-575.
34. Boring C, Squires T, Ting T. Cancer Statistics CA 1993; 43: 7-26.
35. Hammond D, Sather H, Nesbit M et al. Analysis of prognostic factors in acute lymphoblastic leukemia. Med Ped Oncol 1986; 14: 124-134.
36. Gaynor J, Chapman D, Little C et al. A cause specific hazard data analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia. The Memorial Hospital experience since 1969. J Clin Oncol 1988; 6: 1014-1030.
37. Brochstein J, Kernan N, Groshen S et al. Allogeneic BMT after hyperfractioned TBI and cyclophosphamide in children with acute leukemia. New Engl J Med 1987; 317: 1618-1624.
38. Henslee-Downey P. Choosing an alternative bone marrow donor among available family members. Am J Pediatr Hematol Oncol 1993; 15: 150-161.
39. Trigg ME. Bone marrow transplantation using alternative donors. Am J Pediatr Hematol Oncol 1993; 15: 141-149.
40. Anasetti C, Beatty PG, Storb R et al. Effect of HLA-incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29: 79-91.